DoD Breast Cancer, Era of Hope Scholar Award | W81XWH 22 BCRP EOHS

Opportunity Information: Apply for W81XWH 22 BCRP EOHS

The DoD Breast Cancer, Era of Hope Scholar Award is a U.S. Department of Defense funding opportunity run through the U.S. Army Medical Research Acquisition Activity (USAMRAA) under the Breast Cancer Research Program. It is designed for early-career investigators who have already shown unusual promise and a clear ability to move their fields forward through creativity, innovation, and strong productivity. The emphasis is less on supporting a single conventional project and more on backing a person who can reshape thinking in breast cancer research. Applicants are expected to present a big-picture vision that challenges existing assumptions and shows how their ideas could meaningfully contribute to ending breast cancer, including approaches that cut across disciplines.

A defining feature of this award is that prior breast cancer research experience is not required. Researchers from other scientific or technical areas are explicitly encouraged to apply if they can bring fresh concepts, tools, or perspectives to breast cancer. Even so, the proposed work must be clearly focused on breast cancer, and the Principal Investigator must commit at least 50 percent of their full-time professional effort to breast cancer research for the duration of the award. That 50 percent effort can be met through a combination of this award and other current support, but the applicant must be able to demonstrate that the time and commitment are real and sustained.

The program expects strong collaboration. Applicants are encouraged to build a research team with the expertise needed to achieve the vision and goals described in the application, and they must include meaningful partnerships. A unique and mandatory element is the inclusion of breast cancer consumer advocates: the research team must include two or more advocates who are breast cancer survivors and are actively involved in a breast cancer advocacy organization. These advocates serve as lay representatives providing independent, objective input throughout the research effort, especially regarding relevance, patient-centered impact, and how the work may affect people with breast cancer or those at risk. They cannot be employees of any organization participating in the application, and their advocate role must be independent of their employment. The opportunity also expects these advocates to be well-informed about current breast cancer issues and to have enough background or training in breast cancer research to contribute constructively.

In administrative terms, the opportunity is listed as Funding Opportunity Number W81XWH-22-BCRP-EOHS, categorized as discretionary funding, with awards made as either grants or cooperative agreements. It falls under CFDA 12.420 (military medical research and development). Eligibility is described as unrestricted, meaning it is broadly open to different entity types unless further limited by any additional eligibility language in the full announcement. The posting indicates an expected total of about two awards. The original posting date was March 16, 2022, with an original closing date of May 17, 2022. The award ceiling is shown as 0 in the source data, which typically signals that a specific cap may be defined elsewhere in the full funding announcement or may vary based on program guidance rather than being expressed as a single fixed maximum in the summary record.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Breast Cancer, Era of Hope Scholar Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Mar 16, 2022.
• Applicants must submit their applications by May 17, 2022. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 2 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 22 BCRP EOHS

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: